Public tenders in Germany

7,249 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tacrolimus, ATC L04AD02 for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 492492-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Emtricitabine + Rilpivirine + Tenofovir disoproxil fumarate, ATC J05AR08 for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 491642-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ranibizumab, ATC S01LA04, for the period 01.09.2026 – 31.08.2028

DAK-Gesundheit, HamburgTED 493717-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Triptorelin, ATC L02AE04 for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 491708-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Abatacept, ATC L04AA24 for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 493555-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance natalizumab (only dosage form ILO), ATC L04AA23, for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 491013-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Drug discount contracts pursuant to § 130a, paragraph 8 of the Social Code Book V (SGB V) within the framework of Open-House procedures

IKK classic, DresdenTED 599075-2026

value not stated24 lots

Wed 5 Jul23:59 in Berlin

615days

Open framework agreement on pharmaceutical discounts pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V), with possibility of accession at any time, so-called approval model 2026-09

Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 468640-2026

value not stated26 lots

Wed 5 Jul23:59 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance combination of Lopinavir and Ritonavir (ATC-Code: J05AR10).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 557912-2026

value not stated1 lot

Thu 27 Jul12:00 in Berlin

637days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Nevirapine (ATC-code: J05AG01)

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 561034-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Naproxen (ATC: M01AE02).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 557099-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Aprepitant (ATC-code: A04AD12).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 563311-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Raltegravir (ATC: J05AJ01).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 559214-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Ipratropium bromide (ATC-code: R03BB01).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 575033-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Brivaracetam (ATC-code: N03AX23).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 577713-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Atomoxetin (ATC-code: N06BA09)

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 559605-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active ingredient Tobramycin (ATC:J01GB01).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 557376-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Glycerol Trinitrate (ATC-code: C01DA02 and C05AE01)

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 560075-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Entecavir (ATC Code: J05AF10).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 557585-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Cariprazine (ATC-code: N05AX15)

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 559811-2026

value not stated1 lot

Fri 28 Jul12:00 in Berlin

638days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.